Amidst the grand success of this action entertainer, Allu Arjun's wife, Sneha Reddy, dropped a sweet post which she dedicated it to her family. Taking to her official Instagram page, Sneha shared ...

Sneha and her brother were adopted by Spanish couple in 2010 from an orphanage in Bhubaneswar, Odisha, after their biological mother abandoned them. A Spanish woman is in India in search of her ...

Sneha is active on her Instagram, and since Arjun’s arrest and bail, she has been sporadic in posting Instagram stories. But her first post on her feed includes photos of her, Arjun, and their ...

As a result, Allu Arjun was arrested and spent a day behind bars. During this challenging time, Allu Arjun’s wife, Sneha Reddy, stood by him like a rock-solid support. Videos of Sneha Reddy ...

The Great Wealth Transfer from baby boomers to Gen X and millennials is often discussed, but with 70% of inheritances projected to go first to women, the industry isn’t talking enough about the ...

Sneha Enrique Vidal a 21-year-old girl from Spain who was adopted as a child from Odisha by a Spanish couple.(PTI) Sneha, a researcher in children's education in Spain, travelled to India to trace ...

Sneha's Spanish parents Gema Vidal and Juan Josh supported her in her quest. Sneha, a Spanish citizen, has returned to India in search of her biological mother, who had abandoned her and her ...

During the arrest and his subsequent release the next day on interim bail, a video of the actor’s wife, Allu Sneha Reddy, hugging him tearfully and standing by him during the tough time went ...

Data for December were not yet available. Kisqali is undergoing “a very rapid launch” in early breast cancer, Novartis CEO Vas Narasimhan said during a media call Friday. As Narasimhan shared ...

These TSX stocks have a high dividend-growth rate. Moreover, these stocks will likely grow their dividends at a solid pace.

Novartis’ head of drug development Vas Narasimhan talks about the company’s stake in CAR-T immunotherapy. These cell therapies are set to transform treatment of blood cancers – but questions ...